Anne E. White
CIK 1752313 · EVP & Pres, Lilly Neuroscience · last filed 2025-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$84.08M
Companies
1
Total Filings
13
Lifetime Open-Market Net
-$1.61M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LLY | EVP & Pres, Lilly Neuroscience | 74,209 | $1133.00 | $84.08M | -$1.61M | 13 | 2025-02-12 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-28 | LLY | Buy (P) | +1,000 | $108.8K | EDGAR |
| 2019-02-06 | LLY | Grant (A) | +7,246 | $870.8K | EDGAR |
| 2018-12-04 | LLY | Mixed | +4,194 | -$392.2K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.